Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

U.K. Biotech Learns Lessons From History, Says BIA Head

This article was originally published in The Pink Sheet Daily

Executive Summary

Adversity has honed a solid foundation for U.K. biotech that might be better placed to resist cyclical changes in investor sentiment than the U.S., proposes the head of the U.K biotech industry association.


Related Content

Deal Watch: Roche Returns To RNAi With Santaris Buyout, While Biogen Re-Ups With Regulus


Related Companies

Related Deals